Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NovoCure LtdNVCR · Entity 4494 | Director · Chief Technology Officer | August 28, 2018 | August 30, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NovoCure Ltd
Report date August 28, 2018 · Filed August 30, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectBennett Limited | 1,041,054 |
Reported balance
After 2018-08-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-08-28 · Sale · Disposed 4,334 · Balance 1,041,054 F1: On August 28, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 4,334 shares in multiple trades at prices ranging from $40.00 to $40.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2: Professor Palti shares voting and investment power for the shares held by Bennett Limited. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 28, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 4,334 shares in multiple trades at prices ranging from $40.00 to $40.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F2: Professor Palti shares voting and investment power for the shares held by Bennett Limited.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2018 Filed Aug 30, 2018 16:09 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,334 | $40.27 | $174,548.82 |
DisclosureSEC source: 0001209191-18-048926 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,041,054 F1 · price: On August 28, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 4,334 shares in multiple trades at prices ranging from $40.00 to $40.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 16:22 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 13,450 | $40.05 | $538,663.09 |
DisclosureSEC source: 0001209191-18-048680 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,045,388 F3 · price: On August 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,450 shares in multiple trades at prices ranging from $40.00 to $40.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| August 24, 2018 Filed Aug 28, 2018 16:22 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 12,216 | $40.00 | $488,644.89 |
DisclosureSEC source: 0001209191-18-048680 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,058,838 F1 · price: On August 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 12,216 shares in multiple trades at prices ranging from $40.00 to $40.05. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 17:14 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 27,685 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-043113 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,071,054 F3 · price: On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,685 shares in multiple trades at prices ranging from $35.00 to $35.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 17:14 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 2,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-043113 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,098,739 F1 · price: On July 16, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,315 shares in multiple trades at prices ranging from $36.00 to $36.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 16:12 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $31.09 | $932,802.00 |
DisclosureSEC source: 0001209191-18-038534 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,101,054 F1 · price: On June 15, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $30.875 to $31.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 16:23 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $31.64 | $949,269.00 |
DisclosureSEC source: 0001209191-18-038048 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,131,054 F1 · price: On June 14, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $31.40 to $31.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 26, 2018 Filed Apr 30, 2018 17:03 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 14,766 | $26.33 | $388,788.78 |
DisclosureSEC source: 0001209191-18-026882 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,161,054 F3 · price: On April 26, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 14,766 shares in multiple trades at prices ranging from $26.00 to $26.75. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 26, 2018 Filed Apr 30, 2018 17:03 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 6,200 | $25.52 | $158,224.00 |
DisclosureSEC source: 0001209191-18-026882 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,175,820 F1 · price: On April 26, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 6,200 shares in multiple trades at prices ranging from $25.00 to $25.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 16:08 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,600 | $25.06 | $140,319.76 |
DisclosureSEC source: 0001209191-18-026066 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,182,020 F3 · price: On April 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 5,600 shares in multiple trades at prices ranging from $25.00 to $25.25. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 16:08 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $25.07 | $751,962.00 |
DisclosureSEC source: 0001209191-18-026066 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,187,620 F1 · price: On April 23, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $25.00 to $25.40. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 19,362 | $25.06 | $485,182.68 |
DisclosureSEC source: 0001209191-18-025821 · doc4.xml · nonDerivative · entry 3 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,217,620 F4 · price: On April 20, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 19,362 shares in multiple trades at prices ranging from $24.575 to $25.30. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 16,081 | $25.06 | $402,989.86 |
DisclosureSEC source: 0001209191-18-025821 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,236,982 F3 · price: On April 19, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 16,081 shares in multiple trades at prices ranging from $25.00 to $25.65. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 13,919 | $24.79 | $345,052.01 |
DisclosureSEC source: 0001209191-18-025821 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,253,063 F1 · price: On April 19, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,919 shares in multiple trades at prices ranging from $24.45 to $24.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 18, 2018 Filed Apr 19, 2018 16:21 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 14,072 | $24.10 | $339,080.32 |
DisclosureSEC source: 0001209191-18-025556 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,266,982 F3 · price: On April 18, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 14,072 shares in multiple trades at prices ranging from $24.00 to $24.50. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 16:21 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $23.44 | $703,224.00 |
DisclosureSEC source: 0001209191-18-025556 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,281,054 F1 · price: On April 17, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $23.00 to $23.85. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 04, 2018 Filed Apr 5, 2018 16:17 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 30,000 | $19.89 | $596,754.00 |
DisclosureSEC source: 0001209191-18-024057 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,311,054 F1 · price: On April 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $19.60 to $20.375. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 03, 2018 Filed Apr 4, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 26,300 | $20.23 | $532,049.00 |
DisclosureSEC source: 0001209191-18-023587 · doc4.xml · nonDerivative · entry 4 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,341,054 F5 · price: On April 3, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 26,300 shares in multiple trades at prices ranging from $20.00 to $20.70. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 03, 2018 Filed Apr 4, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 3,700 | $19.87 | $73,519.00 |
DisclosureSEC source: 0001209191-18-023587 · doc4.xml · nonDerivative · entry 3 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,367,354 F4 · price: On April 3, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 3,700 shares in multiple trades at prices ranging from $19.65 to $19.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 27,489 | $20.38 | $560,225.82 |
DisclosureSEC source: 0001209191-18-023587 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,371,054 F3 · price: On April 2, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,489 shares in multiple trades at prices ranging from $20.00 to $20.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 2,511 | $21.36 | $53,634.96 |
DisclosureSEC source: 0001209191-18-023587 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,398,543 F1 · price: On April 2, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,511 shares in multiple trades at prices ranging from $21.00 to $21.70. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 4,300 | $22.00 | $94,600.00 |
DisclosureSEC source: 0001209191-18-022352 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,401,054 F3 · price: On March 29, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 4,300 shares in multiple trades at prices ranging from $21.95 to $22.10. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary shares | 25,700 | $21.61 | $555,377.00 |
DisclosureSEC source: 0001209191-18-022352 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,405,354 F1 · price: On March 29, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 25,700 shares in multiple trades at prices ranging from $20.95 to $21.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 16:25 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $17.13 | $513,870.00 |
DisclosureSEC source: 0001209191-17-060601 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,431,054 F1 · price: On November 13, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $16.925 to $17.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 16:36 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 3,900 | $18.04 | $70,356.00 |
DisclosureSEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 6 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,461,054 F7 · price: On November 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 3,900 shares in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 16:36 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 26,100 | $17.54 | $457,794.00 |
DisclosureSEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 5 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,464,954 F6 · price: On November 10, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 26,100 shares in multiple trades at prices ranging from $17.20 to $17.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:36 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,388 | $18.74 | $100,971.12 |
DisclosureSEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 4 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,491,054 F5 · price: On November 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 5,388 shares in multiple trades at prices ranging from $18.65 to $19.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:36 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 24,612 | $18.14 | $446,461.68 |
DisclosureSEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 3 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,496,442 F4 · price: On November 9, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 24,612 shares in multiple trades at prices ranging from $17.65 to $18.625. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:36 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 6,266 | $20.17 | $126,385.22 |
DisclosureSEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,521,054 F3 · price: On November 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 6,266 shares in multiple trades at prices ranging from $20.00 to $20.50. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:36 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 23,734 | $19.46 | $461,863.64 |
DisclosureSEC source: 0001209191-17-060319 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,527,320 F1 · price: On November 8, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 23,734 shares in multiple trades at prices ranging from $19.10 to $19.975. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 07, 2017 Filed Nov 8, 2017 16:17 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 2,900 | $21.14 | $61,306.00 |
DisclosureSEC source: 0001209191-17-059744 · doc4.xml · nonDerivative · entry 3 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,551,054 F4 · price: On November 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 2,900 shares in multiple trades at prices ranging from $20.975 to $21.40. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 07, 2017 Filed Nov 8, 2017 16:17 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 27,100 | $20.34 | $551,214.00 |
DisclosureSEC source: 0001209191-17-059744 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,553,954 F3 · price: On November 7, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 27,100 shares in multiple trades at prices ranging from $19.90 to $20.90. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 16:17 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $21.71 | $651,240.00 |
DisclosureSEC source: 0001209191-17-059744 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,581,054 F1 · price: On November 6, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.45 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 03, 2017 Filed Nov 6, 2017 16:22 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $21.66 | $649,680.00 |
DisclosureSEC source: 0001209191-17-059405 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,611,054 F3 · price: On November 3, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.35 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 16:22 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 30,000 | $21.78 | $653,520.00 |
DisclosureSEC source: 0001209191-17-059405 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Bennett Limited Disclosed balance after: 1,641,054 F1 · price: On November 2, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 30,000 shares in multiple trades at prices ranging from $21.50 to $22.00. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Professor Palti shares voting and investment power for the shares held by Bennett Limited. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 17:17 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 3,825 | $13.82 | $52,842.38 |
DisclosureSEC source: 0001209191-17-038176 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On June 5, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 3,825 shares in multiple trades at prices ranging from $13.70 to $13.95. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 16:19 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $13.49 | $53,956.00 |
DisclosureSEC source: 0001209191-17-037699 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,825 F2 · price: On June 2, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $13.00 to $13.70. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 16:19 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $13.05 | $52,184.00 |
DisclosureSEC source: 0001209191-17-037699 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,825 F1 · price: On June 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.60 to $13.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:29 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $12.47 | $49,892.00 |
DisclosureSEC source: 0001209191-17-036790 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,825 F2 · price: On May 31, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.15 to $12.65. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:29 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $12.50 | $50,004.00 |
DisclosureSEC source: 0001209191-17-036790 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,825 F1 · price: On May 30, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.375 to $12.70. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2017 Filed May 30, 2017 17:08 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $12.86 | $51,440.00 |
DisclosureSEC source: 0001209191-17-036163 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,825 F2 · price: On May 26, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.65 to $13.10. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 25, 2017 Filed May 30, 2017 17:08 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $12.89 | $51,564.00 |
DisclosureSEC source: 0001209191-17-036163 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,825 F1 · price: On May 25, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $12.55 to $13.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2017 Filed May 25, 2017 16:21 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 1,431 | $13.43 | $19,215.47 |
DisclosureSEC source: 0001209191-17-035351 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,825 F2 · price: On May 24, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 1,431 shares in multiple trades at prices ranging from $13.25 to $13.60. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2017 Filed May 25, 2017 16:21 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 2,569 | $13.00 | $33,397.00 |
DisclosureSEC source: 0001209191-17-035351 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,256 F1 · price: On May 24, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 2,569 shares in multiple trades at prices ranging from $12.25 to $13.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2017 Filed May 24, 2017 16:31 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $11.80 | $47,200.00 |
DisclosureSEC source: 0001209191-17-034948 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,825 F2 · price: On May 23, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.55 to $12.25. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 22, 2017 Filed May 24, 2017 16:31 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $11.67 | $46,676.00 |
DisclosureSEC source: 0001209191-17-034948 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,825 F1 · price: On May 22, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.575 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 19, 2017 Filed May 22, 2017 16:14 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $11.54 | $46,144.00 |
DisclosureSEC source: 0001209191-17-034278 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,825 F2 · price: On May 19, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.30 to $11.75. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 18, 2017 Filed May 22, 2017 16:14 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $11.24 | $44,956.00 |
DisclosureSEC source: 0001209191-17-034278 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,825 F1 · price: On May 18, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.05 to $11.50. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:52 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $11.47 | $45,884.00 |
DisclosureSEC source: 0001209191-17-033702 · doc4.xml · nonDerivative · entry 1 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,825 F1 · price: On May 17, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.30 to $11.80. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2017 Filed May 17, 2017 16:14 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 4,000 | $11.90 | $47,604.00 |
DisclosureSEC source: 0001209191-17-033045 · doc4.xml · nonDerivative · entry 2 Palti Yoram · CIK 0001654403 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,825 F2 · price: On May 16, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.75 to $12.075. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.